Literature DB >> 838205

Persistent metabolic abnormalities in diabetes in the absence of glucagon.

A J Barnes, S R Bloom, K Mashiter, K G Alberti, P Smythe, D Turnell.   

Abstract

In order to investigate the contribution of glucagon to the abnormalities of carbohydrate and lipid metabolism in diabetes, hormones and metabolites were measured in response to IV arginine in 5 juvenile onset (control) diabetics and 5 totally pancreatectomised subjects. In the basal state, both control diabetics and pancreatectomised patients showed abnormally elevated levels of plasma glucose, blood 3-hydroxybutyrate, glycerol and plasma free fatty acids (NEFA), although no glucagon was detectable in the plasma of the pancreatectomised subjects. Blood concentrations of the gluconeogenic precursors alanine and glycerol were higher pancreatectomised patients than in the diabetics. Following infusion of arginine, the rise in glucagon observed in the diabetics was accompanied by a significant increase in plasma glucose and a fall in blood lactate when compared to the pancreatectomised subjects. In spite of the rise in glucagon in the control diabetics, no sigficant change was found in the concentrations of ketone bodies, glycerol or NEFA. Thus glucagon does not seem to have a primary role in producing the metabolic abnormalities of diabetes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 838205     DOI: 10.1007/BF00996330

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Total Pancreatectomy for Hyperinsulinism Due to an Islet-Cell Adenoma: Survival and Cure at Sixteen MOnths after Operation Presentation of Metabolic Studies.

Authors:  J T Priestley; M W Comfort; J Radcliffe
Journal:  Ann Surg       Date:  1944-02       Impact factor: 12.969

Review 2.  The hormonal control of hepatic gluconeogenesis.

Authors:  J H Exton; L E Mallette; L S Jefferson; E H Wong; N Friedmann; T B Miller; C R Park
Journal:  Recent Prog Horm Res       Date:  1970

3.  [A new determination of the neutral fats in blood serum and tissue. I. Principles, procedure, and discussion of the method].

Authors:  M Eggstein; F H Kreutz
Journal:  Klin Wochenschr       Date:  1966-03-01

4.  Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.

Authors:  R S Sherwin; M Fisher; R Hendler; P Felig
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

5.  Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.

Authors:  J E Gerich; M Lorenzi; D M Bier; V Schneider; E Tsalikian; J H Karam; P H Forsham
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

6.  Is glucagon important in stable insulin-dependent diabetics?

Authors:  A J Barnes; A Bloom; M F Crowley; J W Tuttlebee; S R Bloom; K G Alberti; P Smythe; D Turnell
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

7.  Pancreatectomised man: A model for diabetes without glucagon.

Authors:  A J Barnes; S R Bloom
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

8.  Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.

Authors:  D S Schade; R P Eaton
Journal:  Diabetes       Date:  1975-05       Impact factor: 9.461

9.  Concentrations of free glucogenic amino acids in livers of rats subjected to various metabolic stresses.

Authors:  D H Williamson; O Lopes-Vieira; B Walker
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

10.  Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.

Authors:  J E Liljenquist; J D Bomboy; S B Lewis; B C Sinclair-Smith; P W Felts; W W Lacy; O B Crofford; G W Liddle
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

View more
  8 in total

Review 1.  Glucagon and diabetes: a reappraisal.

Authors:  P J Lefebvre; A S Luyckx
Journal:  Diabetologia       Date:  1979-06       Impact factor: 10.122

2.  Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.

Authors:  S Del Prato; S Vigili de Kreutzenberg; R Trevisan; E Duner; A Avogaro; R Nosadini; U Baccaglini; C Tremolada; A Tiengo
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

3.  Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell function.

Authors:  R Assan; S Efendic; R Luft; E Cerasi
Journal:  Diabetologia       Date:  1981-11       Impact factor: 10.122

4.  The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes.

Authors:  I Aydin; P Raskin; R H Unger
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

5.  Diabetogenic role of insulin's counterregulatory hormones in the isletectomized, diabetic goby.

Authors:  J T Haigwood; R M Flores; R Mazloumi; G Ngan; K M Kelley
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

6.  Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.

Authors:  W A Muller; M Berger; P Suter; H J Cüppers; J Reiter; T Wyss; P Berchtold; F H Schmidt; J P Assal; A E Renold
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Glucagon and carbohydrate disorder in a totally pancreatectomized man (a study with the aid of an artificial endocrine pancreas).

Authors:  F Santeusanio; M Massi-Benedetti; G Angeletti; G Calabrese; A Bueti; P Brunetti
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

8.  Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy.

Authors:  S Del Prato; A Tiengo; U Baccaglini; C Tremolada; E Duner; M C Marescotti; A Avogaro; I Valverde; R Nosadini; R Assan
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.